Seroprevalence of five neglected parasitic diseases among immigrants accessing five infectious and tropical diseases units in Italy: a cross-sectional study

Martelli, Giulia; Girolamo, Chiara Di; Zammarchi, Lorenzo; Angheben, Andrea; Morandi, Matteo; Tais, Stefano; Degani, Monica; Hamad, Issa El; Caligaris, Silvio; Ciannameo, Anna; Grilli, Elisabetta; Urbinati, L.; Monteiro, Geraldo Badona; Scarcella, Carmelo; Petrosillo, Nicola; Digaetano, Margherita; Rabbi, L.; Bazzanini, N.; Cacciatore, Francesco; Marta, Brigida Lilia; Moro, M. J.; Bartoloni, Alessandro; Viale, Pierluigi; Verucchi, Gabriella

doi:10.1016/j.cmi.2017.02.024

Cited by 38 publications

(35 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Spanish studies have recorded the seroprevalence of Chagas disease among Latin American immigrants as ranging from 2.5% to 22.3% [24][25][26], while our study obtained a seroprevalence of 7.39%. Compared with other European countries, our seroprevalence was not as high as previously reported [27]. The wide range of seroprevalence reflects the heterogeneity of the population as determined by the geographical area, diagnostic test performed and study design.…”

Section: Discussioncontrasting

confidence: 74%

Usefulness of the ARCHITECT Chagas^® assay as a single test for the diagnosis of chronic Chagas disease

Pérez‐Ayala

Fradejas

Rebollo

et al. 2018

Tropical Med Int Health

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 74%

Usefulness of the ARCHITECT Chagas^® assay as a single test for the diagnosis of chronic Chagas disease

Pérez‐Ayala

Fradejas

Rebollo

et al. 2018

Tropical Med Int Health

View full text Add to dashboard Cite

show abstract

“…Available data suggest that it is known to vary substantially, depending on the country of origin, being particularly high in people coming from countries such as Cambodia (36%) or Latin American countries (26%) [21]. Hospital-based prevalence studies conducted in specialized units have suggested that the prevalence of S.stercoralis is between 4.5% and 11% in migrant populations [22][23][24]. Available data suggest a higher prevalence of infection in immunosuppressed individuals at risk [25][26][27].…”

Section: Introductionmentioning

confidence: 99%

High Prevalence of Strongyloidiasis in Spain: A Hospital-Based Study

et al. 2020

View full text Add to dashboard Cite

Introduction: Strongyloidiasis is a prevailing helminth infection ubiquitous in tropical and subtropical areas, however, seroprevalence data are scarce in migrant populations, particularly for those coming for Asia. Methods: This study aims at evaluating the prevalence of S. stercoralis at the hospital level in migrant populations or long term travellers being attended in out-patient and in-patient units as part of a systematic screening implemented in six Spanish hospitals. A cross-sectional study was conducted and systematic screening for S. stercoralis infection using serological tests was offered to all eligible participants. Results: The overall seroprevalence of S. stercoralis was 9.04% (95%CI 7.76-10.31). The seroprevalence of people with a risk of infection acquired in Africa and Latin America was 9.35% (95%CI 7.01-11.69), 9.22% (7.5-10.93), respectively. The number of individuals coming from Asian countries was significantly smaller and the overall prevalence in these countries was 2.9% (95%CI −0.3-6.2). The seroprevalence in units attending Pathogens 2020, 9, 107 2 of 13 potentially immunosuppressed patients was significantly lower (5.64%) compared with other units of the hospital (10.20%) or Tropical diseases units (13.33%) (p < 0.001). Conclusions: We report a hospital-based strongyloidiasis seroprevalence of almost 10% in a mobile population coming from endemic areas suggesting the need of implementing strongyloidiasis screening in hospitalized patients coming from endemic areas, particularly if they are at risk of immunosuppression.

show abstract

“…Bilharziose / Schistosomiasis ist eine Infektionskrankheit, die insbesondere bei Flüchtlingen und Migranten aus Afrika häufig anzutreffen ist. Die Angaben zur Prä valenz schwanken in der Literatur sehr [6][7][8][9][10][11], zweifelsohne ist die Bilharziose aber eine der bedeutendsten parasitären Erkrankungen in diesem Kollektiv und auch weltweit eine der häufigsten tropischen Infektionskrankheiten.…”

Section: Zusammenfassungunclassified

Schistosomiasis bei Flüchtlingen und Migranten

Hennigs

Schmiedel

2018

Flug u Reisemed

View full text Add to dashboard Cite

ZusammenfassungBilharziose / Schistosomiasis ist eine bei Flüchtlingen (insbesondere aus Afrika) häufig auftretende, meist asymptomatische Infektionskrankheit mit möglicherweise schwerwiegenden Komplikationen. Ein serologisches Screening bei allen Menschen aus Endemieregionen und ein Versuch des Einachweises in Stuhl oder Urin bei positiver Screeningserologie sollte durchgeführt werden. Eine positive Serologie rechtfertigt auch bei negativem direkten Parasitennachweis eine einmalige probatorische Therapie 1.

show abstract

Seroprevalence of five neglected parasitic diseases among immigrants accessing five infectious and tropical diseases units in Italy: a cross-sectional study

Cited by 38 publications

References 22 publications

Usefulness of the ARCHITECT Chagas^® assay as a single test for the diagnosis of chronic Chagas disease

Usefulness of the ARCHITECT Chagas^® assay as a single test for the diagnosis of chronic Chagas disease

High Prevalence of Strongyloidiasis in Spain: A Hospital-Based Study

Schistosomiasis bei Flüchtlingen und Migranten

Contact Info

Product

Resources

About

Seroprevalence of five neglected parasitic diseases among immigrants accessing five infectious and tropical diseases units in Italy: a cross-sectional study

Cited by 38 publications

References 22 publications

Usefulness of the ARCHITECT Chagas® assay as a single test for the diagnosis of chronic Chagas disease

Usefulness of the ARCHITECT Chagas® assay as a single test for the diagnosis of chronic Chagas disease

High Prevalence of Strongyloidiasis in Spain: A Hospital-Based Study

Schistosomiasis bei Flüchtlingen und Migranten

Contact Info

Product

Resources

About

Usefulness of the ARCHITECT Chagas^® assay as a single test for the diagnosis of chronic Chagas disease

Usefulness of the ARCHITECT Chagas^® assay as a single test for the diagnosis of chronic Chagas disease